AlzChem AG is planning an initial public offering (IPO) in the regulated market (Prime Standard) of the Frankfurt Stock Exchange in the first half of 2017. The planned proceeds of approximately €40 to €50 million from the capital increase as part of the IPO are intended to be invested to a large extent in the construction of a new production facility for the specialty chemical product CreAMINO at the Trostberg site.